Bioengineering yields new approaches for diagnosing and treating traumatic brain injury

Journal of Neurotrauma is an authoritative peer-reviewed journal published monthly in print and online that focuses on the latest advances in the clinical and laboratory investigation of traumatic brain and spinal cord injury. Emphasis is on the basic pathobiology of injury to the nervous system, and the papers and reviews evaluate preclinical and clinical trials targeted at improving the early management and long-term care and recovery of patients with traumatic brain injury. Credit: Copyright Mary Ann Liebert, Inc., publishers

Bioengineering -- the application of engineering principles to understand and treat medical conditions -- is delivering innovative solutions for diagnosing and repairing damage to the brain caused by a traumatic injury. A broad sample of these new, cutting-edge techniques is presented in a special issue of Journal of Neurotrauma, a peer-reviewed journal published by Mary Ann Liebert, Inc.

The issue captures the broad scope of current and future diagnostic and therapeutic strategies being developed based on novel biomaterials, innovative applications of biomechanics, and advanced simulation and computational technology. Guest Editors Michelle C. LaPlaca, PhD, Associate Professor of Biomedical Engineering, Georgia Tech College of Engineering, and David F. Meaney, PhD, Associate Director, Penn Center for and Repair, and Professor and Chair, Department of Bioengineering, University of Pennsylvania, have compiled a fascinating collection of articles that describe leading research in the areas of three-dimensional cell and tissue preparations designed to study the effects of and to stimulate , computer modeling, and novel imaging and analytical techniques being applied to advance neurotrauma research and patient care.

Original research articles featured in this issue of include "A Detailed Viscoelastic Characterization of the P17 and Adult Rat Brain," by Benjamin Elkin et al.; "Survival Risk Assessment for Primary Blast Exposures to the Head," by Karin Rafaels and colleagues; and "Toward a Convergence of Regenerative Medicine, Rehabilitation, and Neuroprosthetics," by Shyam Aravamudhan et al.

"The Journal is pleased to publish this issue which addresses many of the bioengineering advances being made in the field of injury. Further, this compendium of manuscripts emphasizes the important, yet underappreciated, fact that biomechanical-induced change distinguishes CNS trauma from all other CNS disorders," says John T. Povlishock, PhD, Editor-in-Chief of Journal of Neurotrauma and Professor, VCU Neuroscience Center, Medical College of Virginia, Richmond.

More information: The entire issue is available online at http:// www.liebertpub.com/neu

Provided by Mary Ann Liebert, Inc.

5 /5 (1 vote)
add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Researcher studies protein's link to heart disease

22 hours ago

(Medical Xpress)—The largest protein known to exist in the human body functions as a molecular spring, and University of Arizona researchers are gaining new insights into its role in heart disease.

The rhythm of everything

22 hours ago

Dawn triggers basic biological changes in the waking human body. As the sun rises, so does heart rate, blood pressure and body temperature. The liver, the kidneys and many natural processes also begin shifting ...

User comments

More news stories

Study suggests new approach to fight lung cancer

Recent research has shown that cancer cells have a much different – and more complex – metabolism than normal cells. Now, scientists at The University of Texas at Dallas have found that exploiting these differences might ...

Getting enough sleep could help prevent type 2 diabetes

Men who lose sleep during the work week may be able to lower their risk of developing Type 2 diabetes by getting more hours of sleep, according to Los Angeles Biomedical Research Institute (LA BioMed) research findings presented ...

Aspirin may fight cancer by slowing DNA damage

Aspirin is known to lower risk for some cancers, and a new study led by a UC San Francisco scientist points to a possible explanation, with the discovery that aspirin slows the accumulation of DNA mutations in abnormal cells ...